Literature DB >> 27957199

Sudden Death After Transcatheter Aortic Valve Implantation. Are Bradyarrhythmias Always The Cause?

Lida P Papavasileiou1, Antonios Halapas2, Michael Chrisocheris2, Kyriakos Bellos3, Nikolaos Bouboulis4, Stratis Pattakos4, Georgios Zervopoulos5, Luca Santini6, Konstantinos Spargias2, Francesco Romeo6, Giovanni Forleo6, Theodoros Apostolopoulos5.   

Abstract

Transcatheter Aortic-Valve Implantation (TAVI) is considered to be highly effective in the treatment of high-risk patients with severe aortic stenosis. After TAVI, the rate of pacemaker implantation is 6.5%-40%. Some reports of sudden death after TAVI are mostly attributed to bradyarrhythmias. We report the case of three patients who experienced sudden cardiac death or aborted sudden cardiac death after TAVI. All patients were affected from ischemic heart disease with an ejection fraction of approximately 40% and underwent pacemaker implantation (PM) after the procedure due to 1rst degree atrioventricular block (AV) and left bundle branch block (LBBB). One of the patients died suddenly 30 days after the procedure. The PM interrogation revealed many episodes of non sustain ventricular tachycardias (NSVT) and one episode of ventricular fibrillation (VF) that led to death. The other two patients had syncope and during PM interrogation episodes of ventricular tachycardia >12 sec were recorded. Patients affected by ischemic heart disease undergoing TAVI, especially with borderline coronary lesions should receive particular attention in order to avoid potentially lethal ventricular arrhythmias. In addition, the physiopathologic mechanism of sudden arrhythmic death in these patients needs to be clarified.

Entities:  

Keywords:  Sudden Death; TAVI

Year:  2015        PMID: 27957199      PMCID: PMC4955883          DOI: 10.4022/jafib.1108

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  30 in total

1.  Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery.

Authors:  Samer A M Nashef; Francois Roques; Bradley G Hammill; Eric D Peterson; Philippe Michel; Frederick L Grover; Richard K H Wyse; T Bruce Ferguson
Journal:  Eur J Cardiothorac Surg       Date:  2002-07       Impact factor: 4.191

Review 2.  Arrhythmic sudden cardiac death: substrate, mechanisms and current risk stratification strategies for the post-myocardial infarction patient.

Authors:  Petros Arsenos; Konstantinos Gatzoulis; Polychronis Dilaveris; George Manis; Dimitrios Tsiachris; Stefanos Archontakis; Apostolos-Ilias Vouliotis; Apostolis H Vouliotis; Skevos Sideris; Christodoulos Stefanadis
Journal:  Hellenic J Cardiol       Date:  2013 Jul-Aug

3.  Potential pro-arrhythmic effect of cardiac resynchronization therapy.

Authors:  Osama Tayeh; Waleed Farouk; Abdo Elazab; Hassan Khald; Antonio Curnis
Journal:  J Saudi Heart Assoc       Date:  2013-05-30

4.  Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes.

Authors:  Peter Wenaweser; Thomas Pilgrim; Nadja Roth; Alexander Kadner; Stefan Stortecky; Bindu Kalesan; Fabienne Meuli; Lutz Büllesfeld; Ahmed A Khattab; Christoph Huber; Balthasar Eberle; Gabor Erdös; Bernhard Meier; Peter Jüni; Thierry Carrel; Stephan Windecker
Journal:  Am Heart J       Date:  2011-05-11       Impact factor: 4.749

5.  The incidence of transcatheter aortic valve implantation-related heart block in self-expandable Medtronic CoreValve and balloon-expandable Edwards valves.

Authors:  Michael Liang; Gerard Devlin; Sanjeevan Pasupati
Journal:  J Invasive Cardiol       Date:  2012-04       Impact factor: 2.022

6.  Cardiac resynchronization therapy improved heart failure after left bundle branch block during transcatheter aortic valve implantation.

Authors:  Kentaro Meguro; Nicolas Lellouche; Emmanuel Teiger
Journal:  J Invasive Cardiol       Date:  2012-03       Impact factor: 2.022

7.  Predictors of permanent pacemaker implantation after Medtronic CoreValve bioprosthesis implantation.

Authors:  Thomas Schroeter; Axel Linke; Martin Haensig; Denis R Merk; Michael A Borger; Friedrich W Mohr; Gerhard Schuler
Journal:  Europace       Date:  2012-06-24       Impact factor: 5.214

Review 8.  Cardiac resynchronization therapy and its potential proarrhythmic effect.

Authors:  Indranill Basu Ray; Lahn Fendelander; Jagmeet P Singh
Journal:  Clin Cardiol       Date:  2007-10       Impact factor: 2.882

9.  The Athens TAVR Registry of newer generation transfemoral aortic valves: 30-day outcomes.

Authors:  Konstantinos Spargias; Konstantinos Toutouzas; Michael Chrissoheris; Andreas Synetos; Antonis Halapas; Ioannis Paizis; Georgios Latsios; Konstantinos Stathogiannis; Konstantinos Stathogianni; Spyridon Papametzelopoulos; Stavros Zanos; Gregory Pavlides; Achileas Zacharoulis; Aias Antoniades; Christodoulos Stefanadis
Journal:  Hellenic J Cardiol       Date:  2013 Jan-Feb

10.  Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience.

Authors:  Alain Cribier; Helene Eltchaninoff; Christophe Tron; Fabrice Bauer; Carla Agatiello; Deborah Nercolini; Sydney Tapiero; Pierre-Yves Litzler; Jean-Paul Bessou; Vasilis Babaliaros
Journal:  J Am Coll Cardiol       Date:  2006-02-09       Impact factor: 24.094

View more
  2 in total

1.  A Case of Bundle Branch Re-entrant Ventricular Tachycardia 1 Year After Transcatheter Aortic Valve Replacement.

Authors:  Amarbir Bhullar; Nikhil Sharma; Rosaline Ma; Tia Bimal; Umair Ansari; Stavros Mountantonakis
Journal:  J Innov Card Rhythm Manag       Date:  2022-08-15

2.  Factors associated with early cardiac complications following transcatheter aortic valve implantation with transapical approach.

Authors:  Vasileios Patris; Konstantinos Giakoumidakis; Mihalis Argiriou; Katerina K Naka; Efstratios Apostolakis; Mark Field; Manoj Kuduvalli; Aung Oo; Stavros Siminelakis
Journal:  Pragmat Obs Res       Date:  2018-07-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.